ReviewPediatric clinics of North America2016
Endocrine Disorders in Cystic Fibrosis.
Review in Pediatric clinics of North America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04379726 (Characterization of β-cell Function and Insulin Sensitivity in Pre-transplant Patients With Cystic Fibrosis), which is not on this map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Characterization of β-cell Function and Insulin Sensitivity in Pre-transplant Patients With Cystic Fibrosis
Who cites it
25 citing papers in PubMed, 50 citations in OpenAlex.
- Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes.Frontiers in endocrinology · 2023Trial
- Effect of backpack carrying on forced vital capacity in cystic fibrosis: A randomized crossover-controlled trial.PloS one · 2018Trial
- Height Velocity in Pediatric Cystic Fibrosis Under Triple CFTR Modulator Therapy: A Real-Life Monocentric Experience.Journal of clinical medicine · 2025Article
- Impact of indoor Air Pollution on the Linear growth of children in Jimma, Ethiopia.BMC public health · 2024Article
- Article
- Article
- Quality of dietary macronutrients is associated with glycemic outcomes in adults with cystic fibrosis.Frontiers in nutrition · 2023Article
- Auxological and Endocrinological Features in Children and Adolescents with Cystic Fibrosis.Journal of clinical medicine · 2022Review
- The role of genetic modifiers, inflammation and CFTR in the pathogenesis of Cystic fibrosis related diabetes.Journal of clinical & translational endocrinology · 2022Article
- An update on methods for assessing bone quality and health in Cystic fibrosis.Journal of clinical & translational endocrinology · 2022Article
- Optimizing sexual and reproductive health across the lifespan in people with cystic fibrosis.Pediatric pulmonology · 2022Review
- Satisfaction and Concerns with Telemedicine Endocrine Care of Patients with Cystic Fibrosis.Telemedicine reports · 2022Article
- Ultrasound findings of pubertal development in girls with cystic fibrosis and their association with clinical outcomes and Tanner staging.Archives of endocrinology and metabolism · 2021Article
- [Cystic fibrosis being a polyendocrine disease (Review)].Problemy endokrinologii · 2021Review
- Automatic referrals within a cystic fibrosis multidisciplinary clinic improve patient evaluation and management.Journal of clinical & translational endocrinology · 2021Article
- Impact of 1h oral glucose tolerance test on the clinical status of adult cystic fibrosis patients over a 4-year period.PloS one · 2021Article
- Article
- GH-IGF-1 Axis in Children with Cystic Fibrosis.Clinical medicine & research · 2019Article
- Impact of CFTR-modulating drugs on GH-IGF-1 axis impairment in adult patients with cystic fibrosis.Journal of endocrinological investigation · 2019Article
- Gender differences in bronchiectasis: a real issue?Breathe (Sheffield, England) · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
Cystic fibrosis is frequently complicated by endocrine disorders. Diabetes can be expected to affect most with CF and pancreatic insufficiency and varies widely in age of onset, but early identification and treatment improve morbidity and mortality. Short stature can be exacerbated by relative delay of puberty and by use of inhaled corticosteroids. Bone disease in CF causes fragility fractures and should be assessed by monitoring bone mineral density and optimizing vitamin D status. Detecting and managing endocrine complications in CF can reduce morbidity and mortality in CF. These complications can be expected to become more common as the CF population ages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.